Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma: A population-based study
- PMID: 35184337
- PMCID: PMC9310738
- DOI: 10.1111/ejh.13757
Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma: A population-based study
Erratum in
-
Risk of multiple myeloma and other malignancies among first-and second-degree relatives of patients with multiple myeloma: A population-based study.Eur J Haematol. 2022 Nov;109(5):597. doi: 10.1111/ejh.13832. Eur J Haematol. 2022. PMID: 36218048 Free PMC article. No abstract available.
Abstract
Objectives: We conducted a population-based study to assess the risk for multiple myeloma (MM) and other cancers in first- and second-degree relatives of MM patients, and to investigate whether evidence of anticipation is present in familial MM.
Methods: We retrieved 24 845 first-degree relatives and 41 008 second-degree relatives of 7847 MM patients, and 86 984 first-degree relatives, and 138 660 second-degree relatives of 26 511 matched controls. A Cox model was used to assess the risk for MM and other cancers in relatives of MM patients. Anticipation was assessed by a Cox model, where all parents and offspring of MM patients were included in the risk set.
Results: In second-degree relatives of MM patients, no overall significant association with an MM diagnosis was observed (HR 1.99; 95%CI:0.86-4.57). In parents and offspring of MM patients, we found no significant difference in the ages at onset of MM (HR 1.28;95% CI:0.50-3.28). In affected parent-offspring pairs, we observed no statistically significant difference in overall survival between the generations (HR 0.74; 95%CI:0.20-2.69).
Conclusions: Overall, second-degree relatives of MM patients were not associated with an increased risk for MM. Our study supports that genetic anticipation is not present in familial MM.
Keywords: hematologic neoplasms; multiple myeloma; population-based study; relatives. anticipation.
© 2022 The Authors. European Journal of Haematology published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors have no competing interests.
References
-
- Meyerding HW. Multiple myeloma. Radiology. 1925;5(2):132‐146.
-
- Grosbois B, Gueguen M, Fauchet R, et al. Multiple myeloma in two brothers. An immunochemical and immunogenetic familial study. Cancer. 1986;58(11):2417‐2421. - PubMed
-
- Deshpande HA, Hu X‐P, Marino P, Jan NA, Wiernik PH. Anticipation in familial plasma cell dyscrasias. Br J Haematol. 1998;103(3):696‐703. - PubMed
-
- Lynch HT, Sanger WG, Pirruccello S, Quinn‐Laquer B, Weisenburger DD. Familial multiple myeloma: a family study and review of the literature. JNCI. 2001;93(19):1479‐1483. - PubMed
-
- Lynch HT, Watson P, Tarantolo S, et al. Phenotypic heterogeneity in multiple myeloma families. J Clin Oncol. 2005;23(4):685‐693. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical